Vivimed Labs Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDANANA0
EBITNANA0
Earning Per Share-9-7-38
Expenses838245374
Net Profit-78-68-329
Net Profit Margin-9-29-176
Operating Profit Margin4-3-100
Profit Before Tax-76-65-331
Dividends Per ShareNANA0
Operation Revenue871239188

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Vivimed Labs is 0 as of 3/4/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20082008200820082023
Operating Activities-4-4-4-435
Investing Activities-45-45-45-45-5
Financing Activities60606060-34
Others00000
Net Cash Flow11111111-3

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20203,068.45104.04-2,948.82223.67
2018312.42-884.38502.63-69.33
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Vivimed Labs is 35 as of 3/4/2024